DCDavid J. Ciufo

David J. Ciufo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David J. Ciufo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Allan M. Grant

    Department of Orthopaedic Surgery, Beaumont Health, Royal Oak, MI

    1 shared publication
  • Corinn K. Gehrke

    Beaumont Health, Departments of Orthopaedic Surgery and Research, Beaumont Research Institute, 3601 West 13 Mile Road, Suite 404, Royal Oak, MI 48073, USA

    1 shared publication
  • Erin A. Baker

    Beaumont Health, Departments of Orthopaedic Surgery and Research, Beaumont Research Institute, 3601 West 13 Mile Road, Suite 404, Royal Oak, MI 48073, USA

    1 shared publication
  • John P. Ketz

    University of Rochester, Department of Orthopaedics and Rehabilitation

    1 shared publication
  • Paul T. Fortin

    Beaumont Health, Departments of Orthopaedic Surgery and Research, Beaumont Research Institute, 3601 West 13 Mile Road, Suite 404, Royal Oak, MI 48073, USA

    1 shared publication
  • Zachary M. Vaupel

    Beaumont Health, Departments of Orthopaedic Surgery and Research, Beaumont Research Institute, 3601 West 13 Mile Road, Suite 404, Royal Oak, MI 48073, USA

    1 shared publication

Latest Publications

  • Tibial torsion correlates with talar morphology

    by David J. Ciufo, Erin A. Baker, Corinn K. Gehrke, Zachary M. Vaupel, Paul T. Fortin


  • Orthogonal Locked Plating for Tibiotalocalcaneal Arthrodesis

    by David J. Ciufo, Allan M. Grant

    Management of concomitant tibiotalar and subtalar arthrosis, particularly in the setting of talar avascular necrosis or deformity, is a challenging problem. There are poor union rates and risk of stress fracture at the proximal aspect of intramedullary devices. Fixation can be poor in the calcaneus and talus with current methods. This study describes the technique of orthogonal plating, using an anatomic precontoured plating system, for tibiotalocalcaneal arthrodesis, with and without bulk allograft. We feel this technique provides increased construct stability and good outcomes, and 2 of our cases are presented that underwent arthrodesis using this construct at a single academic center. Level of Evidence: Therapeutic level IV, case series. See Instructions for Authors for a complete description of levels of evidence.


  • Proximal Femoral Shortening and Varus Collapse After Fixation of “Stable” Pertrochanteric Femur Fractures

    by David J. Ciufo, John P. Ketz

    Objectives: To evaluate and compare femoral neck shortening and varus collapse in stable pertrochanteric femur fractures treated with sliding hip screws (SHSs) or cephalomedullary nails (CMNs). Design: Retrospective review. Setting: Academic medical center. Patients: A total of 290 patients were included in the study. The average age was 82 years, and most were women. All sustained low-energy pertrochanteric femur fractures (OTA/AO A1.1, 1.2, 1.3, 2.2) treated operatively with SHSs or CMNs. Minimum radiographic follow-up was 3 months, with an average of 28 (range 3–162) months. Intervention: CMN or SHS fixation. Main Outcome Measures: Varus collapse of the femoral neck-shaft angle and proximal femoral shortening. Results: Both implants allowed some varus collapse. Univariate analysis demonstrated a significantly greater portion of patients with SHSs progressed to varus collapse >5 degrees (P = 0.02), mild horizontal shortening >5 mm (P < 0.01), and severe horizontal shortening >10 mm (P < 0.01). There was no statistical difference in vertical shortening (P = 0.3). There was no difference in implant failure (P = 0.5), with failure rates of 3% for cephalomedullary implants and 5% for SHS constructs. Conclusions: The SHS group experienced greater varus collapse and horizontal shortening. There was no difference in overall implant failure. These findings suggest that the CMN is a superior construct for maintenance of reduction in stable pertrochanteric fractures, which may lead to improved functional outcomes as patients recover. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.